Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalit Landesman-Milo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan Peer
Bioconjugate Chemistry|January 7, 2016
Transforming Nanomedicines From Lab Scale Production to Novel Clinical ModalityDalit Landesman-Milo, Dan Peer
Cancer Metastasis Reviews|May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapyDalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting|April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticlesSrinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Cancer Letters|April 30, 2013
eIF3c: a potential therapeutic target for cancerRafi Emmanuel, Shiri Weinstein, Dalit Landesman-Milo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Current Progress in Non-viral RNAi-Based Delivery Strategies to LymphocytesShoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, et al.
Frontiers in Immunology|February 22, 2017
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based NanoparticlesShoshy Mizrahy, Inbal Hazan-Halevy, Dalit Landesman-Milo, et al.
Applied Optics|November 22, 2018
Combined reflectance spectroscopy and coherent light backscattering measurement differentiate cervical cancer from normal epithelial tissue in a xenograft mouse modelOz Seadia, Dalit Landesman-Milo, Tania Kosoburd, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2016
Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicinesInbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan Peer
Bioconjugate Chemistry|January 7, 2016
Transforming Nanomedicines From Lab Scale Production to Novel Clinical ModalityDalit Landesman-Milo, Dan Peer
Cancer Metastasis Reviews|May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapyDalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting|April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticlesSrinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Cancer Letters|April 30, 2013
eIF3c: a potential therapeutic target for cancerRafi Emmanuel, Shiri Weinstein, Dalit Landesman-Milo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Current Progress in Non-viral RNAi-Based Delivery Strategies to LymphocytesShoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, et al.
Frontiers in Immunology|February 22, 2017
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based NanoparticlesShoshy Mizrahy, Inbal Hazan-Halevy, Dalit Landesman-Milo, et al.
Applied Optics|November 22, 2018
Combined reflectance spectroscopy and coherent light backscattering measurement differentiate cervical cancer from normal epithelial tissue in a xenograft mouse modelOz Seadia, Dalit Landesman-Milo, Tania Kosoburd, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2016
Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicinesInbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, et al.
Pageof 2